-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$26.00-45.54% Downside
Vera Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Vera Therapeutics, Inc.?
Vera Therapeutics, Inc. has been rated by research analysts at Wedbush, Raymond James, Jefferies, H.C. Wainwright, J.P. Morgan in the past 90 days.